Crossmark

Uso del 177Lu-DOTATATE como terapia en carcinomas de tiroides yodorrefractarios

Crossref DOI link: https://doi.org/10.1016/j.remn.2016.08.001

Published Print: 2017-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Oliván-Sasot, P.

Falgás-Lacueva, M.

García-Sánchez, J.

Vera-Pinto, V.

Olivas-Arroyo, C.

Bello-Arques, P.
License Information

Text and Data Mining valid from 2017-03-01
More Information

This article is maintained by: Elsevier

Article Title: Uso del 177Lu-DOTATATE como terapia en carcinomas de tiroides yodorrefractarios

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remn.2016.08.001

Content Type: simple-article

Copyright: © 2016 Elsevier España, S.L.U. y SEMNIM. All rights reserved.